Pancreas/Pancreatic Cancer Metastatics
Showing 1 - 25 of >10,000
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer Trial in Quebec city (Cholesterol metabolism disruption)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +3 more
- Cholesterol metabolism disruption
-
Quebec city, Quebec, CanadaCHU de Québec-Université Laval
Oct 17, 2022
Use Of Indocyanine Green In Pancreas Surgery
Not yet recruiting
- Pancreatic Carcinoma
- Non-Interventional Study
-
Portland, OregonOHSU Knight Cancer Institute
Oct 11, 2023
PAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREAS Trial (blood sampling at inclusion, 6 months, 1 year and 2 years. Tumor
Not yet recruiting
- PAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREAS
- blood sampling at inclusion, 6 months, 1 year and 2 years. Tumor and intracystic fluid samples are taken only if a biopsy is planned following MRI results.
- (no location specified)
Aug 17, 2023
Radiotherapy - Comprehensive Radiobiology Assessment TRial
Not yet recruiting
- Locally Advanced Cervical Carcinoma
- +9 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 1, 2023
Improving Pancreatic Cancer Care by Use of Computational Science
Recruiting
- Pancreatic Cancer
- +5 more
- No interventions
-
Utrecht, NetherlandsRegional Academic Cancer Center Utrecht
Sep 22, 2023
Pancreas Cancer, Pancreas Adenocarcinoma Trial in Cleveland (Capecitabine)
Not yet recruiting
- Pancreas Cancer
- Pancreas Adenocarcinoma
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Seidman Cancer Ce
Oct 29, 2023
Pancreas Cancer, Pancreas Adenocarcinoma, Lymph Node Metastasis Trial in Denmark, Sweden (PALN resection)
Recruiting
- Pancreas Cancer
- +2 more
- PALN resection
-
Odense, Denmark
- +5 more
Sep 26, 2023
Pancreas Cancer, Pancreatitis, Chronic Pancreatitis Trial in New York
Recruiting
- Pancreas Cancer
- +5 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
May 18, 2022
Pancreatic Cancer Screening for At-risk Individuals
Recruiting
- Pancreatic Cancer, Adult
- Screening for pancreatic cancer
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 2, 2023
Pancreatic Cancer Trial in Baltimore (Tislelizumab, SX-682)
Not yet recruiting
- Pancreatic Cancer
-
Baltimore, MarylandJohns Hopkins SKCCC
Jan 23, 2023
Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +2 more
- Enfortumab vedotin
-
Kansas City, KansasUniversity of Kansas Cancer Center
Jun 23, 2023
Metastatic Pancreatic Adenocarcinoma Trial in Baltimore (Epacadostat, Pembrolizumab, CRS-207)
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- Epacadostat
- +4 more
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 3, 2023
Survival, Quality of Life and Resectability in Locally Advanced
Recruiting
- Pancreas Cancer
- +8 more
-
Umeå, SwedenSurgical Clinic at Umeå University Hospital
Nov 23, 2022
Pancreas Adenocarcinoma Trial in Suwon (Pancreatic ductal adenocarcinoma organoids and cancer-associated fibroblasts
Recruiting
- Pancreas Adenocarcinoma
- Pancreatic ductal adenocarcinoma organoids and cancer-associated fibroblasts establishment group
-
Suwon, Gyeong Gi Do, Korea, Republic ofAjou University Hospital
Oct 7, 2022
Radiology Registry on Pancreatic Malignancies
Recruiting
- Pancreatic Cancer
- +3 more
- Radiology evaluations and interventions
-
Milan, ItalyDepartment of Radiology, IRCCS Ospedale San Raffaele
Feb 3, 2023
Predicts Lymph Node Metastasis in Resectable Adenocarcinoma of
Completed
- Pancreas Cancer
- (no location specified)
Jul 15, 2023
Pancreas Cancer Trial (mRNA expression)
Not yet recruiting
- Pancreas Cancer
- mRNA expression
- (no location specified)
Aug 8, 2022
Cancer of Pancreas, Chemo Effect, Metastatic Pancreatic Cancer Trial in Shibin Al Kawm (Gemcitabine fluorouracil)
Completed
- Cancer of Pancreas
- +2 more
- Gemcitabine fluorouracil
-
Shibīn Al Kawm, Menoufia, EgyptMenoufia University, Faculty of medicine
Aug 5, 2022
Pancreatic Ductal Adenocarcinoma Trial in Durham (HA Chemotherapy)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- HA Chemotherapy
-
Durham, North CarolinaDuke University Health System
Nov 22, 2022
Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas Trial in Boston (ZIMBERELIMAB,
Recruiting
- Pancreatic Cancer
- +3 more
- ZIMBERELIMAB
- +3 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 9, 2023
Pancreatic Cancer, Cancer of the Pancreas, Pancreas Cancer Trial in Saint Louis (CDX-301, CDX-1140, Research blood draw)
Recruiting
- Pancreatic Cancer
- +2 more
- CDX-301
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 17, 2023
Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas Trial in Saint Louis (Dapagliflozin, BIOSENSE meters)
Completed
- Pancreas Cancer
- +2 more
- Dapagliflozin
- BIOSENSE meters
-
Saint Louis, MissouriWashington University School of Medicine
Dec 20, 2022
Metastatic Pancreatic Cancer Trial (FOLFIRINOX treatment)
Not yet recruiting
- Metastatic Pancreatic Cancer
- FOLFIRINOX treatment
- (no location specified)
Aug 9, 2023
Prehabilitation, Pancreas Cancer, Surgery Trial in Netherlands (Preoperative optimisation program)
Not yet recruiting
- Prehabilitation
- +3 more
- Preoperative optimisation program
-
Amsterdam, Netherlands
- +14 more
May 1, 2023